TipRanks
Arcus Biosciences Inc (RCUS)
NYSE:RCUS
US Market
RCUS
Arcus Biosciences
RESEARCH TOOLSreports
Want to see RCUS full AI Analyst Report?

Arcus Biosciences (RCUS) Stock News & Sentiment

548 Followers
Arcus Biosciences Completes Early Cancer Trial for AB801, Setting Up Next Pipeline Moves
Premium
Company Announcements
Arcus Biosciences Completes Early Cancer Trial for AB801, Setting Up Next Pipeline Moves
3m ago
RCUS
Arcus Maintained at Hold as Balanced Risk-Reward Persists; $29 Price Target Reaffirmed
Premium
Ratings
Arcus Maintained at Hold as Balanced Risk-Reward Persists; $29 Price Target Reaffirmed
4d ago
RCUS
Analyst Reiterates Buy on Arcus Biosciences, Maintains $46 Price Target Amid Optimism for Casdatifan Triplet Regimen
Premium
Ratings
Analyst Reiterates Buy on Arcus Biosciences, Maintains $46 Price Target Amid Optimism for Casdatifan Triplet Regimen
12d ago
RCUS
Arcus Buy Rating Reiterated as Casdatifan Data Catalysts Approach; Price Target Maintained at $46
Premium
Ratings
Arcus Buy Rating Reiterated as Casdatifan Data Catalysts Approach; Price Target Maintained at $46
26d ago
RCUS
Arcus Biosciences Nears Key Data Milestone in Pancreatic Cancer Trial
Premium
Company Announcements
Arcus Biosciences Nears Key Data Milestone in Pancreatic Cancer Trial
1M ago
RCUS
Arcus Biosciences Advances Casdatifan With New Liver Function Study
Premium
Company Announcements
Arcus Biosciences Advances Casdatifan With New Liver Function Study
1M ago
RCUS
Arcus Biosciences Bets Big on Casdatifan Pipeline
Premium
Company Announcements
Arcus Biosciences Bets Big on Casdatifan Pipeline
2M ago
RCUS
More RCUS News >

RCUS News on the Web

Arcus Buy Rating Reiterated as Casdatifan Data Catalysts Approach; Price Target Maintained at $46
TipRanks News
Bullish
Arcus Biosciences Sinks As Lead Cancer Drug Faces Test
TipRanks News
Bearish
Arcus Biosciences price target raised to $40 from $35 at Truist
TipRanks News
Bullish
Arcus Biosciences Bets Big on Casdatifan Pipeline
TipRanks News
Neutral
Arcus Biosciences price target raised to $42 from $34 at Goldman Sachs
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Ocular Therapeutix (OCUL) and Arcus Biosciences (RCUS)
TipRanks News
Bullish
An Arcus Insider Sold 68,569 Shares but Kept 1.2 Million After a 200% Run
The Motley Fool
Bullish
Arcus Biosciences Advances Casdatifan With New Phase 1 Bioequivalence Study
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
RCUS
Sector Average
Media Buzz
This Week3 articles
Weekly Average4 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is RCUS’s Media Buzz Sentiment?
3 articles about RCUS were published this week. In an average week, 4 articles are published.
    What is RCUS’s weekly average amount of articles?
    In an average week, 4 articles about RCUS are published.
      What is RCUS’s News Sentiment?
      100% of articles about RCUS were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        AMGNAmgen
        MCKMcKesson
        ONCBeOne Medicines
        NVSNovartis
        NTRANatera
        Showing the stocks with the most bullish news sentiment over the past week